Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125610541 | 12561054 | 1 | I | 20160705 | 20160715 | 20160715 | EXP | JP-MYLANLABS-2016M1029057 | MYLAN | IGARASHI, S. THREE CASES OF CONTRAST AGENT-INDUCED ANAPHYLACTIC SHOCK EXPERIENCED. THIS DEPARTMENT. THE 25TH MEETING OF THE JAPANESE SOCIETY OF INTENSIVE CARE MEDI. 2016;25:57 | 0.00 | Y | 0.00000 | 20160715 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125610541 | 12561054 | 1 | PS | EPINEPHRINE. | EPINEPHRINE | 1 | Intramuscular | 0.3 MG SINGLE | U | 19430 | INJECTION | ||||||||
| 125610541 | 12561054 | 2 | C | ARTIST | CARVEDILOL | 1 | Oral | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125610541 | 12561054 | 1 | Anaphylactic shock |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125610541 | 12561054 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125610541 | 12561054 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |